Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 19.56 billion as of November 3, 2025. Its market cap has decreased by -16.92% in one year.

Market Cap

19.56B

Enterprise Value

19.41B

Revenue

2.40B

Ranking

n/a

PE Ratio

397.20

Stock Price

12.13

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 19.56B, an increase of 43.45%. That is a compound annual growth rate of 2.44%.

Market Cap History

Date	Market Cap	% Change
Oct 31, 2025	19.56B	1.24%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	59.52B	19.33%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	421.16B
WuXi AppTec	294.61B
Shenzhen Mindray Bio-Medical Electronics	260.07B
Sichuan Biokin Pharmaceutical	153.99B
Shanghai United Imaging Healthcare	114.74B
Aier Eye Hospital Group	113.87B
Zhangzhou Pientzehuang Pharmaceutical.,	107.81B
Yunnan Baiyao Group Co.,Ltd	101.10B

Market Cap Rankings